Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

Summary

To evaluate the change in quality of life (NEI VFQ 25) in subjects with DME during the first year of treatment with aflibercept according to the EU Label.

Timeline

Start

2015-11-19

Primary completion

2017-08-09

Completion

2017-08-09

Drugs

Indications